Implication for transglutaminase 2-mediated activation of β-catenin signaling in neointimal vascular smooth muscle cells in chronic cardiac allograft rejection

Journal of Heart and Lung Transplantation

Volumn 31, Issue 9, 2012, Pages 1009-1017

  Beazley, Kelly E ^a   Zhang, Tianshu ^a,b   Lima, Florence ^a   Pozharskaya, Tatyana ^a   Niger, Corinne ^a   Tzitzikov, Erdyni ^a   Azimzadeh, Agnes M ^a   Nurminskaya, Maria ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

catenin signaling; cardiac allograft vasculopathy; platelet derived growth factor; transglutaminase 2; vascular smooth muscle cells

Indexed keywords

AXIN; AXIN 2; BETA CATENIN; CELL PROTEIN; CYCLIN D1; DICKKOPF 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; LYMPHOID ENHANCER FACTOR 1; NUMB PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; REGULATOR PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 4; TCF4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG; WISP 1 PROTEIN; WNT1 PROTEIN; WNT2 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CELL PROLIFERATION; CHRONIC CARDIAC ALLOGRAFT REJECTION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; NEOINTIMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BETA CATENIN; CHRONIC DISEASE; GRAFT REJECTION; GTP-BINDING PROTEINS; HEART TRANSPLANTATION; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; SIGNAL TRANSDUCTION; TRANSGLUTAMINASES;

EID: 84864954242     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.04.009     Document Type: Article

References (44)

1. R.N. Mitchell Graft vascular disease: immune response meets the vessel wall Annu Rev Pathol 4 2009 19 47
2. X.M. Zhao, T.K. Yeoh, W.H. Frist, D.L. Porterfield, G.G. Miller Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts Analysis by PCR, in situ hybridization, and immunohistochemistry Circulation 90 1994 677 685
3. K. Lemstrom, R. Sihvola, P. Koskinen Expression of platelet-derived growth factor in the development of cardiac allograft vasculopathy in the rat Transplant Proc 29 1997 1045 1046
4. M.R. Abid, K. Yano, S. Guo Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia J Biol Chem 280 2005 29864 29873
5. M.V. Autieri Antiproliferative effects of immunosuppressant drugs on vascular smooth muscle cells: an additional advantage for attenuating transplant vasculopathy Drug News Perspect 17 2004 110 116
6. I.J. Sanchez-Lazaro, L. Almenar, L. Martinez-Dolz Proliferation signal inhibitors in heart transplantation: a 5-year experience Transplant Proc 42 2010 2992 2993
7. D.O. Taylor, J. Stehlik, L.B. Edwards Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009 J Heart Lung Transplant 28 2009 1007 1022
8. M. Hendrickx, L. Leyns Non-conventional Frizzled ligands and Wnt receptors Dev Growth Differ 50 2008 229 243
9. C.Y. Logan, R. Nusse The Wnt signaling pathway in development and disease Annu Rev Cell Dev Biol 20 2004 781 810
10. M.L. Johnson, N. Rajamannan Diseases of Wnt signaling Rev Endocr Metab Disord 7 2006 41 49
11. B.T. MacDonald, K. Tamai, X. He Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev Cell 17 2009 9 26
12. E.H. Jho, T. Zhang, C. Domon, C.K. Joo, J.N. Freund, F. Costantini Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway Mol Cell Biol 22 2002 1172 1183
13. H. Quasnichka, S.C. Slater, C.A. Beeching, M. Boehm, G.B. Sala-Newby, S.J. George Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression Circ Res 99 2006 1329 1337
14. M. Katoh, M. Katoh NUMB is a break of WNT-Notch signaling cycle Int J Mol Med 18 2006 517 521
15. V.A. Perez, Z. Ali, T.P. Alastalo BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways J Cell Biol 192 2011 171 188
16. E.D. Cohen, K. Ihida-Stansbury, M.M. Lu, R.A. Panettieri, P.L. Jones, E.E. Morrisey Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway J Clin Invest 119 2009 2538 2549
17. A. Tsaousi, H. Williams, C.A. Lyon Wnt4/beta-catenin signaling induces VSMC proliferation and is associated with intimal thickening Circ Res 108 2011 427 436
18. L. Faverman, L. Mikhaylova, J. Malmquist, M. Nurminskaya Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells FEBS Lett 582 2008 1552 1557
19. K.E. Beazley, S. Deasey, F. Lima, M.V. Nurminskaya Transglutaminase 2-mediated activation of beta-catenin signaling has a critical role in warfarin-induced vascular calcification Arterioscler Thromb Vasc Biol 32 2012 123 130
20. L. Lorand, R.M. Graham Transglutaminases: crosslinking enzymes with pleiotropic functions Nat Rev Mol Cell Biol 4 2003 140 156
21. E.A. Zemskov, I. Mikhailenko, E.P. Smith, A.M. Belkin Tissue transglutaminase promotes PDGF/PDGFR-mediated signaling and responses in vascular smooth muscle cells J Cell Physiol 227 2012 2089 2096
22. T.S. Lai, Y. Liu, W. Li, C.S. Greenberg Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells FASEB J 21 2007 4131 4143
23. D.C. Sane, J.L. Kontos, C.S. Greenberg Roles of transglutaminases in cardiac and vascular diseases Front Biosci 12 2007 2530 2545
24. B.R. Cho, M.K. Kim, D.H. Suh Increased tissue transglutaminase expression in human atherosclerotic coronary arteries Coron Artery Dis 19 2008 459 468
25. A. Pistea, E.N. Bakker, J.A. Spaan, M.R. Hardeman, R.N. van, E. VanBavel Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases J Vasc Res 45 2008 10 18
26. S. Schenk, D.D. Kish, C. He Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells J Immunol 174 2005 3741 3748
27. M. Isobe, E. Haber, B.A. Khaw Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts Circulation 84 1991 1246 1255
28. M. Sho, S.E. Sandner, N. Najafian New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs Ann Surg 236 2002 667 675
29. W. Habeler, S. Pouillot, A. Plancheron, M. Puceat, M. Peschanski, C. Monville An in vitro beating heart model for long-term assessment of experimental therapeutics Cardiovasc Res 81 2009 253 259
30. N. Nanda, S.E. Iismaa, W.A. Owens, A. Husain, F. Mackay, R.M. Graham Targeted inactivation of Gh/tissue transglutaminase II J Biol Chem 276 2001 20673 20678
31. C.H. Park, J.Y. Chang, E.R. Hahm, S. Park, H.K. Kim, C.H. Yang Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells Biochem Biophys Res Commun 328 2005 227 234
32. R.E. Watts, M. Siegel, C. Khosla Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles J Med Chem 49 2006 7493 7501
33. J.S. Shao, S.L. Cheng, J.M. Pingsterhaus, N. Charlton-Kachigian, A.P. Loewy, D.A. Towler Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals J Clin Invest 115 2005 1210 1220
34. M.C. Mancini, J.T. Evans Role of platelet-derived growth factor in allograft vasculopathy Ann Surg 231 2000 682 688
35. A.M. Goodwin, P.A. D'Amore Wnt signaling in the vasculature Angiogenesis 5 2002 1 9
36. M.E. van Gijn, M.J. Daemen, J.F. Smits, W.M. Blankesteijn The wnt-frizzled cascade in cardiovascular disease Cardiovasc Res 55 2002 16 24
37. X. Wang, N. Adhikari, Q. Li, J.L. Hall LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells Am J Physiol Heart Circ Physiol 287 2004 H2376 H2383
38. F.C. Caira, S.R. Stock, T.G. Gleason Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation J Am Coll Cardiol 47 2006 1707 1712
39. T.M. Grzeszkiewicz, V. Lindner, N. Chen, S.C. Lam, L.F. Lau The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans Endocrinology 143 2002 1441 1450
40. D. Morrow, S. Guha, C. Sweeney Notch and vascular smooth muscle cell phenotype Circ Res 103 2008 1370 1382
41. L. Yang, C. Lin, S. Zhao, H. Wang, Z.R. Liu Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression J Biol Chem 282 2007 16811 16819
42. E.A. Zemskov, E. Loukinova, I. Mikhailenko, R.A. Coleman, D.K. Strickland, A.M. Belkin Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase J Biol Chem 284 2009 16693 16703
43. M. Siegel, C. Khosla Transglutaminase 2 inhibitors and their therapeutic role in disease states Pharmacol Ther 115 2007 232 245
44. K. Inoki, H. Ouyang, T. Zhu TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth Cell 126 2006 955 968